{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:00:00Z","timestamp":1781244000801,"version":"3.54.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plasma cell mastitis (PCM) is a benign immune-mediated inflammatory breast disease predominantly affecting non-lactating women. In pregnant patients, conventional treatments carry significant maternal-fetal safety risks, creating an unmet need for safe, non-invasive therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 30-year-old primigravida at 16\u202fweeks of gestation presented with a giant (&amp;gt;15\u202fcm), antibiotic-refractory left breast PCM. She declined systemic corticosteroids and surgical intervention due to fetal safety concerns. An individualized three-stage topical herbal residue dressing regimen was implemented, with dynamic prescription adjustments from mass resolution to wound healing to postpartum consolidation. Oral herbal medicine was added postpartum when fetal safety was no longer a constraint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical cure was achieved, defined as complete resolution of the palpable mass and ulcer healing. A notable discordance between clinical and imaging recovery was observed, with residual hypoechoic areas requiring over 1 year to achieve near-complete resolution. The patient remained recurrence-free throughout a 3-year follow-up period, including a 2-year treatment-free phase. A healthy full-term infant was delivered vaginally with normal neonatal development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that staged topical herbal therapy may represent a potential option for managing gestational PCM in carefully selected patients. These findings may serve as a reference for clinicians managing similar cases but require confirmation through larger controlled studies before definitive clinical recommendations can be made.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1848671","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:47:21Z","timestamp":1781243241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Staged topical herbal therapy for giant plasma cell mastitis in pregnancy with 3-year follow-up"],"prefix":"10.3389","volume":"13","author":[{"given":"Chao","family":"Gao","sequence":"first","affiliation":[{"name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Niu","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2997891","DOI":"10.1155\/tbj\/2997891","article-title":"Management of idiopathic granulomatous mastitis: effectiveness of a steroid-free regimen using Tinospora cordifolia-a single-institution experience","volume":"2025","author":"Das Sheth","year":"2025","journal-title":"Breast J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1431681","DOI":"10.3389\/fimmu.2024.1431681","article-title":"Novel insights: crosstalk with non-puerperal mastitis and immunity","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/CM9.0000000000001532","article-title":"Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021","volume":"134","author":"Zhou","year":"2021","journal-title":"Chin Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2026.0613","article-title":"American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2025 guidelines for the Management of Infectious and Inflammatory Lesions of the breast","author":"Mitchell","year":"2026","journal-title":"JAMA Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.5858\/arpa.2024-0461-RA","article-title":"The pathologic spectrum of pregnancy- and lactation-associated breast lesions","volume":"149","author":"Ajmal","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2024.4303","article-title":"Neurodevelopmental outcomes after late preterm antenatal corticosteroids","volume":"331","author":"Gyamfi-Bannerman","year":"2024","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00268-022-06687-7","article-title":"Management of granulomatous lobular mastitis and risk factors associated with recurrence","volume":"46","author":"Tian","year":"2022","journal-title":"World J Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.asjsur.2022.08.020","article-title":"Inflammatory breast cancer was misdiagnosed as plasma cell mastitis: a case report","volume":"46","author":"Kang","year":"2023","journal-title":"Asian J Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ard.2025.02.021","article-title":"Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations","volume":"84","author":"Pluma","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/pathogens12121385","article-title":"Pharmacokinetics and safety of group A and B anti-tuberculosis drugs used in treatment of rifampicin-resistant tuberculosis during pregnancy and post-partum: a narrative review","volume":"12","author":"Hughes","year":"2023","journal-title":"Pathogens"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2672157","DOI":"10.1155\/tbj\/2672157","article-title":"Treatment outcomes of lobular granulomatous mastitis: impact of hyperprolactinemia, diabetes, and erythema nodosum-insights from a 7-year cohort study","volume":"2026","author":"AkbariRad","year":"2026","journal-title":"Breast J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e241232","DOI":"10.1136\/bcr-2020-241232","article-title":"Idiopathic granulomatous mastitis diagnosed during pregnancy associated with successful breastfeeding experience","volume":"14","author":"Awomolo","year":"2021","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/medicina59081418","article-title":"Granulomatous mastitis occurring during pregnancy: a case report","volume":"59","author":"Yoshino","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"583120","DOI":"10.2147\/IJWH.S583120","article-title":"Targeted duct excision reduces recurrence and shortens treatment duration in periductal mastitis: a retrospective cohort study","volume":"18","author":"Wang","year":"2026","journal-title":"Int J Women's Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21037\/abs-22-23","article-title":"Can imaging findings predict the outcome of idiopathic granulomatous mastitis?","volume":"7","author":"Ozcan","year":"2023","journal-title":"Ann Breast Surg"},{"key":"ref17","volume-title":"Li Yue Pian Wen","author":"Wu","year":"2018"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e2400510","DOI":"10.1002\/smtd.202400510","article-title":"Advanced Thermoactive nanomaterials for thermomedical tissue regeneration: opportunities and challenges","volume":"9","author":"Li","year":"2025","journal-title":"Small Methods"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.20047\/j.issn1673-7210.2023.31.31","article-title":"Zhang Xiaojun jiaoshou zhongyao waifu zhiliao yunqi jiangxibao ruxianyan jingyan [Professor Zhang Xiaojun\u2019s experience in treating plasma cell mastitis during pregnancy with external application of Chinese herbal medicine]","volume":"20","author":"Liu","year":"2023","journal-title":"Zhongguo Yiyao Daobao"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2022.11.119","article-title":"Formulation development and evaluation of transdermal patch of astaxanthin","author":"Kaur","year":"2022","journal-title":"Mater Today Proc"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/ptr.8140","article-title":"The anti-inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: prenylation and methoxylation beneficially enhance bioactivity and skin targeting","volume":"38","author":"Lin","year":"2024","journal-title":"Phytother Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4062\/biomolther.2022.004","article-title":"The long search for pharmacologically useful anti-inflammatory flavonoids and their action mechanisms: past, present, and future","volume":"30","author":"Kim","year":"2022","journal-title":"Biomol Ther (Seoul)"},{"key":"ref23","first-page":"234","article-title":"Correlation between immune factor expression and prognosis of plasma cell mastitis surgery and its predictive value for prognosis","volume-title":"Clin Exp Obstet Gynecol","author":"Li","year":"2024"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"121617","DOI":"10.1016\/j.jep.2026.121617","article-title":"Discovery of antibacterial active components from the root barks of Sophora flavescens and evaluation of their antibacterial in vitro and infected wound healing activity in vivo","volume":"366","author":"Li","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"121058","DOI":"10.1016\/j.jep.2025.121058","article-title":"Osthole promotes skin flap survival by inhibiting ferroptosis and alleviating pyroptosis","volume":"358","author":"Xu","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"ref26","volume-title":"Pharmacopoeia of the People\u2019s Republic of China","year":"2025"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/pharmaceutics13070960","article-title":"Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities","volume":"13","author":"Neupane","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.3390\/molecules25215051","article-title":"Transdermal delivery systems of natural products applied to skin therapy and care","volume":"25","author":"Cheng","year":"2020","journal-title":"Molecules"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1848671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:47:36Z","timestamp":1781243256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1848671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":28,"alternative-id":["10.3389\/fmed.2026.1848671"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1848671","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"article-number":"1848671"}}